申请人:Shanghai Zhimeng Biophama Co., Ltd.
公开号:US20190152963A1
公开(公告)日:2019-05-23
The present invention discloses a pyrazole-oxazolidinone compound having anti-hepatitis B virus activity, which has the structure of formula (I), wherein each variable is as defined herein.
本发明公开了一种具有抗乙型肝炎病毒活性的吡唑-噁唑烷酮化合物,其具有如下式(I)的结构,其中每个变量如本文所定义。